Business Practice

In a world of regulatory rigor and complex supply chains, product recalls are becoming increasingly challenging.

Hiring gifted new employees is tough enough, but how do you keep them within your organization once you’ve got them?

Mysterious cyber attackers are hitting pharma manufacturing systems

New Alzheimer’s treatment gets $500 million collaborative boost

Opportunistic investors surf the wave of experimental treatments

Merck KGaA snaps up Sigma-Aldrich, Allergan fights Valeant, and Shire–Abbvie deal sours

“Welcome to Big Pharma, where you can make a fortune and still maintain a healthy conscience. Or can you?”

Antibiotics were once hailed as wonder drugs in the war against infection, but now it looks like bacteria might have the upper hand. How can we turn the tide?

An FDA Warning Letter can be a real wake up call. How can you address the root of the problem?

Sitting Down With… Wim Leereveld, founder and CEO of the Access to Medicine Foundation